1	If	if	IN	_	3	mark	_
2	you	you	PRP	_	3	nsubj	3:A1=PPT
3	are	be	VBP	pb=be.01	11	advcl	11:AM-ADV
4	interested	interested	JJ	_	3	acomp	3:A2=PRD
5	in	in	IN	_	4	prep	_
6	this	this	DT	_	7	det	_
7	story	story	NN	_	5	pobj	_
8	,	,	,	_	11	punct	_
9	you	you	PRP	_	11	nsubj	11:A1=PPT
10	might	might	MD	_	11	aux	11:AM-MOD
11	be	be	VB	pb=be.01	0	root	_
12	interested	interested	JJ	_	11	acomp	11:A2=PRD
13	in	in	IN	_	12	prep	_
14	others	other	NNS	_	13	pobj	_
15	from	from	IN	_	14	prep	_
16	The	the	DT	_	18	det	_
17	Journal	journal	NNP	_	18	nn	_
18	Gazette	gazette	NNP	_	15	pobj	_
19	.	.	.	_	11	punct	_

1	Go	go	VB	pb=go.02	0	root	_
2	to	to	IN	p2=TO	1	prep	1:A4=GOL
3	www.journalgazette.net/newsletter	#url#	ADD	_	2	pobj	_
4	and	and	CC	_	1	cc	_
5	pick	pick	VB	pb=pick.01	1	conj	_
6	the	the	DT	_	7	det	_
7	subjects	subject	NNS	_	5	dobj	5:A1=PPT
8	you	you	PRP	_	9	nsubj	9:A0=PPT
9	care	care	VBP	pb=care.01	7	rcmod	_
10	most	most	RBS	p2=JJS	9	advmod	9:AM-EXT
11	about	about	IN	p2=RB	9	prep	9:A1=PAG
12	.	.	.	_	1	punct	_

1	We	we	PRP	_	3	nsubj	3:A0=PAG
2	'll	will	MD	_	3	aux	3:AM-MOD
3	deliver	deliver	VB	pb=deliver.01	0	root	_
4	your	your	PRP$	_	8	poss	_
5	customized	customize	VBN	p2=JJ|pb=customize.01	8	amod	_
6	daily	daily	JJ	_	8	amod	_
7	news	news	NN	_	8	nn	_
8	report	report	NN	_	3	dobj	3:A1=PPT;5:A1=PPT
9	at	at	IN	_	3	prep	3:AM-TMP
10	3	0	CD	_	14	num	_
11	a.m.	a.m.	NN	p2=RB	14	nn	_
12	Fort	fort	NNP	_	13	nn	_
13	Wayne	wayne	NNP	_	14	nn	_
14	time	time	NN	_	9	pobj	_
15	,	,	,	_	16	punct	_
16	right	right	UH	p2=RB	3	intj	3:AM-DIS
17	to	to	IN	_	16	prep	_
18	your	your	PRP$	_	19	poss	_
19	email	email	NN	_	17	pobj	_
20	.	.	.	_	3	punct	_

1	LONDON	london	NNP	p2=NN	3	hmod	_
2	-	-	HYPH	p2=:	3	hyph	_
3	Researchers	researchers	NNP	p2=NNPS	0	root	_
4	in	in	IN	_	3	prep	_
5	the	the	DT	_	7	det	_
6	English	english	JJ	p2=NNP	7	amod	_
7	city	city	NN	_	4	pobj	_
8	of	of	IN	_	7	prep	_
9	Cambridge	cambridge	NNP	_	8	pobj	_
10	,	,	,	_	9	punct	_
11	birthplace	birthplace	NN	_	9	appos	_
12	of	of	IN	_	11	prep	_
13	the	the	DT	_	14	det	_
14	world	world	NN	_	19	poss	_
15	's	's	POS	_	14	possessive	_
16	best	well	RBS	_	18	hmod	_
17	-	-	HYPH	_	18	hyph	_
18	selling	sell	VBG	_	19	amod	_
19	drug	drug	NN	_	12	pobj	_
20	and	and	CC	_	19	cc	_
21	47	0	CD	_	23	num	_
22	Nobel	nobel	NNP	_	23	nn	_
23	Prizes	prize	NNPS	_	19	conj	_
24	in	in	IN	_	23	prep	_
25	medicine	medicine	NN	_	24	pobj	_
26	and	and	CC	_	25	cc	_
27	chemistry	chemistry	NN	_	25	conj	_
28	through	through	IN	_	11	prep	_
29	its	its	PRP$	_	30	poss	_
30	university	university	NN	_	28	pobj	_
31	,	,	,	_	32	punct	_
32	have	have	VBP	p2=VBZ|pb=have.03	0	root	_
33	little	little	JJ	_	34	amod	_
34	faith	faith	NN	_	32	dobj	32:A1=PPT
35	in	in	IN	_	34	prep	_
36	Pfizer	pfizer	NNP	_	38	poss	_
37	's	's	POS	_	36	possessive	_
38	vision	vision	NN	_	35	pobj	_
39	for	for	IN	_	38	prep	_
40	AstraZeneca	astrazeneca	NNP	_	39	pobj	_
41	.	.	.	_	32	punct	_

1	AstraZeneca	astrazeneca	NNP	_	4	nsubj	4:A0=PAG;6:A0=PAG
2	has	have	VBZ	_	4	aux	_
3	been	be	VBN	_	4	aux	_
4	planning	plan	VBG	pb=plan.01	0	root	_
5	to	to	TO	_	6	aux	_
6	move	move	VB	pb=move.01	4	xcomp	4:A1=PPT
7	its	its	PRP$	_	8	poss	_
8	headquarters	headquarters	NN	p2=NNS	6	dobj	6:A1=PPT
9	from	from	IN	_	8	prep	_
10	London	london	NNP	_	9	pobj	_
11	to	to	IN	_	9	prep	_
12	Cambridge	cambridge	NNP	_	11	pobj	_
13	in	in	IN	_	6	prep	6:AM-TMP
14	2016	0	CD	_	13	pobj	_
15	at	at	IN	_	6	prep	6:AM-MNR
16	a	a	DT	_	17	det	_
17	cost	cost	NN	_	15	pobj	_
18	of	of	IN	_	17	prep	_
19	$	$	$	_	21	quantmod	_
20	558	0	CD	_	21	number	_
21	million	#crd#	CD	_	18	pobj	_
22	.	.	.	_	4	punct	_

1	Now	now	RB	_	19	advmod	19:AM-TMP
2	,	,	,	_	19	punct	_
3	with	with	IN	_	11	mark	_
4	New	new	NNP	_	5	nn	_
5	York	york	NNP	p2=NN	7	hmod	_
6	-	-	HYPH	_	7	hyph	_
7	based	base	VBN	_	9	amod	_
8	Pfizer	pfizer	NNP	p2=NN	9	nn	_
9	bidding	bidding	NN	p2=VBG	11	nsubj	11:A0=PAG
10	to	to	TO	p2=IN	11	aux	_
11	buy	buy	VB	pb=buy.01	19	advcl	19:AM-ADV
12	AstraZeneca	astrazeneca	NNP	_	11	dobj	11:A1=PPT
13	,	,	,	_	19	punct	_
14	the	the	DT	_	15	det	_
15	fate	fate	NN	_	19	nsubj	19:A1=PPT
16	of	of	IN	_	15	prep	_
17	British	british	JJ	_	18	amod	_
18	science	science	NN	_	16	pobj	_
19	is	be	VBZ	pb=be.01	0	root	_
20	up	up	RB	p2=RP	19	advmod	19:A2=PRD
21	in	in	IN	_	20	prep	_
22	the	the	DT	_	23	det	_
23	air	air	NN	_	21	pobj	_
24	.	.	.	_	19	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	nsubj	3:A0=PAG;5:A0=PAG;9:A0=PAG
2	has	have	VBZ	_	3	aux	_
3	vowed	vow	VBN	pb=vow.01	0	root	_
4	to	to	TO	_	5	aux	_
5	complete	complete	VB	pb=complete.01	3	xcomp	3:A1=PPT
6	the	the	DT	_	7	det	_
7	facility	facility	NN	_	5	dobj	5:A1=PPT
8	and	and	CC	_	5	cc	_
9	keep	keep	VB	pb=keep.04	5	conj	_
10	at	at	RB	p2=IN	11	advmod	_
11	least	least	RBS	_	12	advmod	_
12	20	0	CD	_	13	num	_
13	percent	percent	NN	_	9	dobj	9:A1=PPT
14	of	of	IN	_	13	prep	_
15	its	its	PRP$	_	17	poss	_
16	research	research	NN	_	17	nn	_
17	workforce	workforce	NN	_	14	pobj	_
18	in	in	IN	_	9	prep	9:A2=PPT
19	Britain	britain	NNP	_	18	pobj	_
20	for	for	IN	_	9	prep	9:AM-TMP
21	five	#crd#	CD	_	22	num	_
22	years	year	NNS	_	20	pobj	_
23	,	,	,	_	9	punct	_
24	alongside	alongside	IN	_	9	prep	_
25	a	a	DT	_	28	det	_
26	similar	similar	JJ	_	28	amod	_
27	research	research	NN	_	28	nn	_
28	hub	hub	NN	_	24	pobj	_
29	in	in	IN	_	28	prep	_
30	Boston	boston	NNP	_	29	pobj	_
31	in	in	IN	_	28	prep	_
32	the	the	DT	_	35	det	_
33	U.S.	u.s.	NNP	_	34	nn	_
34	Yet	yet	NNP	p2=CC	35	nn	_
35	interviews	interview	NNS	p2=VBZ	31	pobj	_
36	with	with	IN	_	35	prep	_
37	many	many	JJ	_	36	pobj	_
38	in	in	IN	_	37	prep	_
39	the	the	DT	_	42	det	_
40	academic	academic	JJ	_	42	amod	_
41	community	community	NN	_	42	nn	_
42	show	show	NN	p2=VBP	38	pobj	_
43	they	they	PRP	_	44	nsubj	44:A1=PPT
44	remain	remain	VBP	pb=remain.01	42	rcmod	_
45	unconvinced	unconvinced	JJ	_	44	acomp	44:A3=PRD
46	.	.	.	_	3	punct	_

1	Memories	memory	NNS	p2=NNP	25	nsubj	25:A1=PPT
2	of	of	IN	_	1	prep	_
3	Pfizer	pfizer	NNP	_	6	poss	_
4	's	's	POS	_	3	possessive	_
5	2011	0	CD	_	6	num	_
6	decision	decision	NN	_	2	pobj	_
7	to	to	TO	_	8	aux	_
8	shut	shut	VB	pb=shut.05	6	infmod	_
9	down	down	RP	_	8	prt	8:C-V
10	research	research	NN	_	8	dobj	8:A1=PPT
11	in	in	IN	_	10	prep	_
12	Sandwich	sandwich	NNP	_	11	pobj	_
13	in	in	IN	_	12	prep	_
14	southeast	southeast	JJ	p2=NNP	15	amod	_
15	England	england	NNP	_	13	pobj	_
16	,	,	,	_	12	punct	_
17	once	once	RB	p2=IN	23	advmod	_
18	the	the	DT	_	19	det	_
19	company	company	NN	_	23	poss	_
20	's	's	POS	_	19	possessive	_
21	biggest	big	JJS	_	23	amod	_
22	European	european	JJ	_	23	amod	_
23	lab	lab	NN	_	12	appos	_
24	,	,	,	_	25	punct	_
25	are	be	VBP	pb=be.01	0	root	_
26	still	still	RB	_	25	advmod	25:AM-TMP
27	fresh	fresh	JJ	_	25	acomp	25:A2=PRD
28	.	.	.	_	25	punct	_

1	Kay	kay	NNP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	he	he	PRP	_	5	nsubj	5:A0=PAG
4	has	have	VBZ	_	5	aux	_
5	spoken	speak	VBN	pb=speak.01	2	ccomp	2:A1=PPT
6	with	with	IN	_	5	prep	5:A2=GOL
7	10	0	CD	_	9	num	_
8	group	group	NN	_	9	nn	_
9	leaders	leader	NNS	_	6	pobj	_
10	at	at	IN	_	5	prep	5:AM-LOC
11	his	his	PRP$	_	12	poss	_
12	laboratory	laboratory	NN	_	10	pobj	_
13	and	and	CC	_	12	cc	_
14	the	the	DT	_	17	det	_
15	nearby	nearby	JJ	p2=RB	17	amod	_
16	Babraham	babraham	NNP	_	17	nn	_
17	Institute	institute	NNP	_	12	conj	_
18	.	.	.	_	2	punct	_

1	While	while	IN	_	3	mark	_
2	all	all	DT	p2=RB	3	nsubj	3:A0=PPT
3	oppose	oppose	VBP	pb=oppose.01	0	root	11:A1-DSP
4	Pfizer	pfizer	NNP	_	6	poss	_
5	's	's	POS	_	4	possessive	_
6	takeover	takeover	NN	_	3	dobj	3:A1=PPT
7	of	of	IN	_	6	prep	_
8	AstraZeneca	astrazeneca	NNP	_	7	pobj	_
9	,	,	,	_	11	punct	_
10	he	he	PRP	_	11	nsubj	11:A0
11	said	say	VBD	pb=say.01	3	parataxis	_
12	,	,	,	_	11	punct	_
13	they	they	PRP	_	14	nsubj	14:A1=PPT;16:A1=PPT
14	're	be	VBP	pb=be.01	2	rcmod	_
15	not	not	RB	_	16	neg	16:AM-NEG
16	opposed	oppose	VBN	p2=JJ|pb=oppose.01	14	acomp	14:A2=PRD
17	to	to	IN	_	16	prep	_
18	Pfizer	pfizer	NNP	_	19	nsubj	19:A1=PPT
19	expanding	expand	VBG	pb=expand.01	17	pcomp	_
20	in	in	IN	_	19	prep	19:AM-LOC
21	Cambridge	cambridge	NNP	_	20	pobj	_
22	independently	independently	RB	_	19	advmod	19:AM-MNR
23	.	.	.	_	14	punct	_

1	We	we	NNP	p2=PRP	3	nsubj	3:A0=PAG
2	would	would	MD	_	3	aux	3:AM-MOD
3	welcome	welcome	VB	pb=welcome.01	12	ccomp	12:A1=PPT
4	it	it	PRP	_	3	dobj	3:A1=PPT
5	as	as	IN	_	3	prep	3:A2=LOC
6	the	the	DT	_	8	det	_
7	best	good	JJS	_	8	amod	_
8	outcome	outcome	NN	_	5	pobj	_
9	,	,	,	_	12	punct	_
10			NNP	p2=''	11	nn	_
11	Kay	kay	NNP	_	12	nsubj	12:A0
12	said	say	VBD	pb=say.01	0	root	_
13	.	.	.	_	12	punct	_

1	Mikael	mikael	NNP	_	2	nn	_
2	Dolsten	dolsten	NNP	_	14	nsubj	14:A0=PAG
3	,	,	,	_	2	punct	_
4	Pfizer	pfizer	NNP	_	6	poss	_
5	's	's	POS	_	4	possessive	_
6	president	president	NN	_	2	appos	_
7	of	of	IN	_	6	prep	_
8	worldwide	worldwide	JJ	p2=JJR	9	amod	_
9	research	research	NN	_	7	pobj	_
10	and	and	CC	_	9	cc	_
11	development	development	NN	_	9	conj	_
12	,	,	,	_	2	punct	_
13	has	have	VBZ	_	14	aux	_
14	compared	compare	VBN	pb=compare.01	0	root	_
15	the	the	DT	_	20	det	_
16	Cambridge	cambridge	NNP	_	18	nn	_
17	,	,	,	_	16	punct	_
18	England	england	NNP	_	20	nn	_
19	,	,	,	_	18	punct	_
20	hub	hub	NN	p2=VBP	14	dobj	14:A1=PPT
21	to	to	IN	_	14	prep	14:A2=PPT
22	Pfizer	pfizer	NNP	_	24	poss	_
23	's	's	POS	_	22	possessive	_
24	facility	facility	NN	_	21	pobj	_
25	in	in	IN	_	24	prep	_
26	Cambridge	cambridge	NNP	_	25	pobj	31:A1=PAG;39:A1=PPT
27	,	,	,	_	26	punct	_
28	Massachusetts	massachusetts	NNP	_	26	appos	_
29	,	,	,	_	26	punct	_
30	which	which	WDT	_	31	nsubj	31:R-A1;39:R-A1
31	sits	sit	VBZ	pb=sit.01	26	rcmod	_
32	across	across	IN	_	31	prep	31:A2=LOC
33	the	the	DT	_	35	det	_
34	Charles	charles	NNP	_	35	nn	_
35	River	river	NNP	_	32	pobj	_
36	from	from	IN	_	31	prep	31:AM-LOC
37	Boston	boston	NNP	_	36	pobj	_
38	and	and	CC	_	31	cc	_
39	is	be	VBZ	pb=be.01	31	conj	_
40	home	home	NN	_	39	attr	39:A2=PRD
41	to	to	IN	_	40	prep	_
42	Harvard	harvard	NNP	_	43	nn	_
43	University	university	NNP	_	41	pobj	_
44	and	and	CC	_	43	cc	_
45	scores	score	NNS	_	43	conj	_
46	of	of	IN	_	45	prep	_
47	biotech	biotech	JJ	p2=NN	48	amod	_
48	companies	company	NNS	_	46	pobj	_
49	.	.	.	_	14	punct	_

1	At	at	IN	_	9	prep	9:AM-LOC
2	Pfizer	pfizer	NNP	_	5	poss	_
3	's	's	POS	_	2	possessive	_
4	Boston	boston	NNP	_	5	nn	_
5	centers	center	NNS	_	1	pobj	_
6	,	,	,	_	9	punct	_
7	the	the	DT	_	8	det	_
8	company	company	NN	_	9	nsubj	17:A0=PAG
9	opens	open	VBZ	pb=open.03	0	root	_
10	up	up	RP	p2=IN	9	prt	9:C-V
11	lab	lab	NN	_	12	nn	_
12	resources	resource	NNS	_	9	dobj	9:A1=PPT
13	to	to	IN	_	9	prep	9:A3
14	local	local	JJ	_	15	amod	_
15	academics	academic	NNS	p2=NN	13	pobj	_
16	to	to	TO	_	17	aux	_
17	help	help	VB	pb=help.01	9	advcl	9:AM-PRP
18	get	get	VB	pb=get.01	17	xcomp	17:A1=PPT
19	ideas	idea	NNS	_	18	dobj	18:A1=PPT
20	for	for	IN	_	19	prep	_
21	drugs	drug	NNS	_	20	pobj	_
22	into	into	IN	_	18	prep	18:A2=DIR
23	the	the	DT	_	24	det	_
24	clinic	clinic	NN	_	22	pobj	_
25	.	.	.	_	9	punct	_

1	Dolsten	dolsten	NNP	p2=RB	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	he	he	PRP	_	4	nsubj	4:A0
4	thought	think	VBD	pb=think.01	2	ccomp	2:A1=PPT
5	a	a	DT	_	7	det	_
6	similar	similar	JJ	_	7	amod	_
7	arrangement	arrangement	NN	_	8	nsubj	8:A1=PPT
8	was	be	VBD	pb=be.01	4	ccomp	4:A1=PPT
9	possible	possible	JJ	_	8	acomp	8:A2=PRD
10	in	in	IN	_	8	prep	8:AM-LOC
11	the	the	DT	_	12	det	_
12	U.K.	u.k.	NNP	_	10	pobj	_
13	The	the	DT	p2=NNP	16	det	_
14	planned	plan	VBN	p2=VBD|pb=plan.01	16	amod	_
15	AstraZeneca	astrazeneca	NNP	p2=JJ	16	nn	_
16	headquarters	headquarters	NN	p2=NNS	26	nsubj	14:A1=PPT;26:A1=PPT
17	and	and	CC	_	16	cc	_
18	research	research	NN	_	19	nn	_
19	facility	facility	NN	_	16	conj	_
20	at	at	IN	_	16	prep	_
21	the	the	DT	_	24	det	_
22	Cambridge	cambridge	NNP	_	23	nn	_
23	Biomedical	biomedical	NNP	p2=JJ	24	nn	_
24	Campus	campus	NN	p2=NNP	20	pobj	_
25	will	will	MD	_	26	aux	26:AM-MOD
26	be	be	VB	pb=be.01	8	advcl	_
27	near	near	IN	_	26	prep	26:A2=PRD
28	the	the	DT	_	29	det	_
29	LMB	lmb	NNP	p2=NN	27	pobj	_
30	and	and	CC	_	26	cc	_
31	a	a	DT	_	32	quantmod	_
32	dozen	dozen	NN	_	35	num	_
33	other	other	JJ	_	35	amod	_
34	research	research	NN	_	35	nn	_
35	centers	center	NNS	_	26	conj	_
36	.	.	.	_	2	punct	_

1	Dolsten	dolsten	NNP	p2=RB	14	nsubj	25:A0=PAG;14:A1=PPT
2	,	,	,	_	1	punct	_
3	Pfizer	pfizer	NNP	_	6	nn	_
4	Chief	chief	NNP	_	6	nn	_
5	Executive	executive	NNP	_	6	nn	_
6	Officer	officer	NNP	_	8	nn	_
7	Ian	ian	NNP	_	8	nn	_
8	Read	read	NNP	_	1	conj	_
9	and	and	CC	_	8	cc	_
10	AstraZeneca	astrazeneca	NNP	_	13	nn	_
11	CEO	ceo	NNP	_	13	nn	_
12	Pascal	pascal	NNP	_	13	nn	_
13	Soriot	soriot	NNP	_	8	conj	_
14	appeared	appear	VBD	pb=appear.01	0	root	_
15	before	before	IN	_	14	prep	14:AM-LOC
16	Parliament	parliament	NNP	_	21	poss	_
17	's	's	POS	_	16	possessive	_
18	Science	science	NNP	_	21	nn	_
19	and	and	CC	_	18	cc	_
20	Technology	technology	NNP	_	18	conj	_
21	Committee	committee	NNP	_	15	pobj	_
22	on	on	IN	_	14	prep	14:AM-TMP
23	Wednesday	wednesday	NNP	_	22	pobj	_
24	to	to	TO	_	25	aux	_
25	answer	answer	VB	pb=answer.01	14	advcl	14:AM-PRP
26	lawmakers	lawmaker	NNS	_	28	poss	_
27	'	'	POS	_	26	possessive	_
28	questions	question	NNS	_	25	dobj	25:A1=PPT
29	about	about	IN	_	28	prep	_
30	the	the	DT	_	31	det	_
31	impact	impact	NN	_	29	pobj	_
32	of	of	IN	_	31	prep	_
33	the	the	DT	_	35	det	_
34	potential	potential	JJ	p2=NN	35	amod	_
35	takeover	takeover	NN	_	32	pobj	_
36	of	of	IN	_	35	prep	_
37	the	the	DT	_	42	det	_
38	second	#ord#	RB	_	40	hmod	_
39	-	-	HYPH	_	40	hyph	_
40	largest	large	JJS	_	42	amod	_
41	U.K.	u.k.	NNP	_	42	nn	_
42	drugmaker	drugmaker	NN	p2=NNP	36	pobj	_
43	.	.	.	_	14	punct	_

1	That	that	DT	_	2	det	_
2	language	language	NN	_	3	nsubj	3:A0=PAG
3	gives	give	VBZ	pb=give.01	12	ccomp	12:A1=PPT
4	Pfizer	pfizer	NNP	p2=NN	9	poss	_
5	an	an	POS	p2=NNP	4	possessive	_
6	easy	easy	JJ	_	9	amod	_
7	opt	opt	NN	_	9	hmod	_
8	-	-	HYPH	_	9	hyph	_
9	out	out	NN	p2=RP	3	dobj	3:A1=PPT
10	,	,	,	_	12	punct	_
11			''	p2=WDT	12	punct	_
12	said	say	VBD	pb=say.01	0	root	_
13	Julian	julian	NNP	_	14	nn	_
14	Huppert	huppert	NNP	_	12	nsubj	12:A0
15	,	,	,	_	14	punct	_
16	a	a	DT	_	17	det	_
17	member	member	NN	_	14	appos	20:A0=PAG
18	of	of	IN	_	17	prep	_
19	Parliament	parliament	NNP	_	18	pobj	_
20	representing	represent	VBG	pb=represent.01	17	partmod	_
21	Cambridge	cambridge	NNP	_	20	dobj	20:A1=PPT
22	.	.	.	_	12	punct	_

1	Britain	britain	NNP	_	9	nsubjpass	9:A2=GOL
2	and	and	CC	_	1	cc	_
3	the	the	DT	_	5	det	_
4	university	university	NN	_	5	nn	_
5	town	town	NN	_	1	conj	_
6	would	would	MD	_	9	aux	9:AM-MOD
7	be	be	VB	_	9	auxpass	_
8	better	good	JJR	p2=RBR	9	advmod	9:AM-ADV
9	served	serve	VBN	p2=VBD|pb=serve.01	23	ccomp	23:A1=PPT
10	if	if	IN	_	14	mark	_
11	Pfizer	pfizer	NNP	p2=NN	14	nsubj	17:A0=PAG;14:A1=PPT
12	and	and	CC	_	11	cc	_
13	AstraZeneca	astrazeneca	NNP	_	11	conj	_
14	remained	remain	VBD	pb=remain.01	9	advcl	9:AM-ADV
15	independent	independent	JJ	_	14	acomp	14:A3=PRD
16	and	and	CC	_	14	cc	_
17	expanded	expand	VBD	p2=VBN|pb=expand.01	14	conj	_
18	their	their	PRP$	_	20	poss	_
19	local	local	JJ	_	20	amod	_
20	operations	operation	NNS	_	17	dobj	17:A1=PPT
21	separately	separately	RB	_	17	advmod	17:AM-MNR
22	,	,	,	_	23	punct	_
23	said	say	VBD	pb=say.01	0	root	_
24	Huppert	huppert	NNP	_	23	nsubj	23:A0
25	,	,	,	_	24	punct	_
26	a	a	DT	_	29	det	_
27	former	former	JJ	_	29	amod	_
28	research	research	NN	_	29	nn	_
29	scientist	scientist	NN	_	24	appos	31:A0=PPT
30	who	who	WP	_	31	nsubj	31:R-A0
31	headed	head	VBD	pb=head.01	29	rcmod	_
32	a	a	DT	_	35	det	_
33	small	small	JJ	_	35	amod	_
34	biotech	biotech	JJ	p2=NN	35	amod	_
35	company	company	NN	_	31	dobj	39:A0=PPT;31:A1=PPT
36	in	in	IN	_	35	prep	_
37	Cambridge	cambridge	NNP	_	36	pobj	_
38	before	before	IN	_	31	prep	31:AM-TMP
39	entering	enter	VBG	pb=enter.01	38	pcomp	_
40	politics	politics	NNS	_	39	dobj	39:A1=LOC
41	.	.	.	_	23	punct	_

1	Andy	andy	NNP	_	2	nn	_
2	Cosh	cosh	NNP	_	15	nsubj	15:A0=PAG
3	,	,	,	_	2	punct	_
4	assistant	assistant	NN	p2=JJ	5	nn	_
5	director	director	NN	_	2	appos	_
6	at	at	IN	_	5	prep	_
7	Cambridge	cambridge	NNP	_	8	nn	_
8	University	university	NNP	_	10	poss	_
9	's	's	POS	_	8	possessive	_
10	Centre	centre	NNP	_	6	pobj	_
11	for	for	IN	_	10	prep	_
12	Business	business	NNP	_	13	nn	_
13	Research	research	NNP	_	11	pobj	_
14	,	,	,	_	15	punct	_
15	agrees	agree	VBZ	pb=agree.01	0	root	_
16	.	.	.	_	15	punct	_

1	If	if	IN	_	3	mark	_
2	Pfizer	pfizer	NNP	_	3	nsubj	3:A0=PAG
3	succeeds	succeed	VBZ	pb=succeed.01	9	advcl	9:AM-ADV
4	in	in	IN	_	3	prep	3:A1=PPT
5	its	its	PRP$	_	6	poss	_
6	takeover	takeover	NN	_	4	pobj	_
7	,	,	,	_	9	punct	_
8	there	there	EX	_	9	expl	_
9	's	be	VBZ	pb=be.02	39	ccomp	39:A1=PPT
10	a	a	DT	_	11	det	_
11	danger	danger	NN	_	9	attr	9:A1=PPT
12	that	that	IN	p2=WDT	35	complm	_
13	the	the	DT	_	14	det	_
14	network	network	NN	_	35	nsubj	35:A0;30:A1=PPT
15	of	of	IN	_	14	prep	_
16	academic	academic	JJ	_	17	amod	_
17	researchers	researcher	NNS	_	15	pobj	27:A1
18	,	,	,	_	17	punct	_
19	consultancies	consultancy	NNS	_	17	conj	_
20	and	and	CC	_	19	cc	_
21	biopharmaceutical	biopharmaceutical	JJ	p2=NN	22	amod	_
22	companies	company	NNS	_	19	conj	_
23	that	that	WDT	p2=IN	27	dobj	27:R-A1
24	Cambridge	cambridge	NNP	_	27	nsubj	27:A0=PAG
25	has	have	VBZ	_	27	aux	_
26	been	be	VBN	_	27	aux	_
27	building	build	VBG	p2=NN|pb=build.01	17	rcmod	_
28	,	,	,	_	14	punct	_
29	largely	largely	RB	_	30	advmod	30:AM-ADV
30	based	base	VBN	pb=base.02	14	partmod	_
31	on	on	IN	_	30	prep	30:A2=DIR
32	personal	personal	JJ	_	33	amod	_
33	contacts	contact	NNS	_	31	pobj	_
34	,	,	,	_	14	punct	_
35	gets	gets	VBZ	p2=NNS|pb=gets.01	11	rcmod	_
36	busted	busted	JJ	p2=VBN	35	oprd	35:A1
37	,	,	,	_	39	punct	_
38			''	p2=NNP	39	punct	_
39	said	say	VBD	pb=say.01	0	root	_
40	Cosh	cosh	NNP	_	39	nsubj	39:A0;44:A0=PAG
41	,	,	,	_	40	punct	_
42	who	who	WP	_	44	nsubj	44:R-A0
43	is	be	VBZ	_	44	aux	_
44	studying	study	VBG	pb=study.01	40	rcmod	_
45	models	model	NNS	_	44	dobj	44:A1=PPT
46	of	of	IN	_	45	prep	_
47	interaction	interaction	NN	_	46	pobj	_
48	between	between	IN	_	47	prep	_
49	the	the	DT	_	50	det	_
50	university	university	NN	_	48	pobj	_
51	and	and	CC	_	50	cc	_
52	businesses	business	NNS	_	50	conj	_
53	.	.	.	_	39	punct	_

